These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38102563)

  • 1. Quantifying and reducing inequity in average treatment effect estimation.
    Nieser KJ; Cochran AL
    BMC Med Res Methodol; 2023 Dec; 23(1):297. PubMed ID: 38102563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.
    Lin CD; Lui KJ
    Pharm Stat; 2022 Mar; 21(2):386-394. PubMed ID: 34755464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model misspecification and bias for inverse probability weighting estimators of average causal effects.
    Waernbaum I; Pazzagli L
    Biom J; 2023 Feb; 65(2):e2100118. PubMed ID: 36045099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covariate adjustment in subgroup analyses of randomized clinical trials: A propensity score approach.
    Yang S; Li F; Thomas LE; Li F
    Clin Trials; 2021 Oct; 18(5):570-581. PubMed ID: 34269087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of average treatment effect based on a multi-index propensity score.
    Xu J; Wei K; Wang C; Huang C; Xue Y; Zhang R; Qin G; Yu Y
    BMC Med Res Methodol; 2022 Dec; 22(1):337. PubMed ID: 36577950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating population treatment effects from a survey subsample.
    Rudolph KE; Díaz I; Rosenblum M; Stuart EA
    Am J Epidemiol; 2014 Oct; 180(7):737-48. PubMed ID: 25190679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random-effects, fixed-effects and the within-between specification for clustered data in observational health studies: a simulation study.
    Dieleman JL; Templin T
    PLoS One; 2014; 9(10):e110257. PubMed ID: 25343620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.
    Di Stefano F; Pannaux M; Correges A; Galtier S; Robert V; Saint-Hilary G
    Stat Med; 2022 May; 41(10):1767-1779. PubMed ID: 35098579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbiased K-L estimator for the linear regression model.
    Aladeitan B; Lukman AF; Davids E; Oranye EH; Kibria GBM
    F1000Res; 2021; 10():832. PubMed ID: 35186270
    [No Abstract]   [Full Text] [Related]  

  • 14. Point estimation following two-stage adaptive threshold enrichment clinical trials.
    Kimani PK; Todd S; Renfro LA; Stallard N
    Stat Med; 2018 Sep; 37(22):3179-3196. PubMed ID: 29855066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity estimation in meta-analysis of standardized mean differences when the distribution of random effects departs from normal: A Monte Carlo simulation study.
    Blázquez-Rincón D; Sánchez-Meca J; Botella J; Suero M
    BMC Med Res Methodol; 2023 Jan; 23(1):19. PubMed ID: 36650428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shrinkage estimation of effect sizes as an alternative to hypothesis testing followed by estimation in high-dimensional biology: applications to differential gene expression.
    Montazeri Z; Yanofsky CM; Bickel DR
    Stat Appl Genet Mol Biol; 2010; 9():Article23. PubMed ID: 20597849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chain ratio estimator and regression estimator with linear combination of two auxiliary variables.
    Lu J
    PLoS One; 2013; 8(11):e81085. PubMed ID: 24260537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal plasmode algorithms to evaluate statistical methods in realistic scenarios: an illustration applied to occupational epidemiology.
    Souli Y; Trudel X; Diop A; Brisson C; Talbot D
    BMC Med Res Methodol; 2023 Oct; 23(1):242. PubMed ID: 37853309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of rare binary events in treatment groups with unequal variability.
    Li L; Wang X
    Stat Methods Med Res; 2019 Jan; 28(1):263-274. PubMed ID: 28760075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.